• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于恶性黑色素瘤腋窝转移辅助治疗的放射治疗野范围

Radiation therapy field extent for adjuvant treatment of axillary metastases from malignant melanoma.

作者信息

Beadle Beth M, Guadagnolo B Ashleigh, Ballo Matthew T, Lee Jeffrey E, Gershenwald Jeffrey E, Cormier Janice N, Mansfield Paul F, Ross Merrick I, Zagars Gunar K

机构信息

Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

出版信息

Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1376-82. doi: 10.1016/j.ijrobp.2008.06.1910. Epub 2008 Sep 5.

DOI:10.1016/j.ijrobp.2008.06.1910
PMID:18774657
Abstract

PURPOSE

To compare treatment-related outcomes and toxicity for patients with axillary lymph node metastases from malignant melanoma treated with postoperative radiation therapy (RT) to either the axilla only or both the axilla and supraclavicular fossa (extended field [EF]).

METHODS AND MATERIALS

The medical records of 200 consecutive patients treated with postoperative RT for axillary lymph node metastases from malignant melanoma were retrospectively reviewed. All patients received postoperative hypofractionated RT for high-risk features; 95 patients (48%) received RT to the axilla only and 105 patients (52%) to the EF.

RESULTS

At a median follow-up of 59 months, 111 patients (56%) had sustained relapse, and 99 patients (50%) had died. The 5-year overall survival, disease-free survival, and distant metastasis-free survival rates were 51%, 43%, and 46%, respectively. The 5-year axillary control rate was 88%. There was no difference in axillary control rates on the basis of the treated field (89% for axilla only vs. 86% for EF; p = 0.4). Forty-seven patients (24%) developed treatment-related complications. On both univariate and multivariate analyses, only treatment with EF irradiation was significantly associated with increased treatment-related complications.

CONCLUSIONS

Adjuvant hypofractionated RT to the axilla only for metastatic malignant melanoma with high-risk features is an effective method to control axillary disease. Limiting the radiation field to the axilla only produced equivalent axillary control rates to EF and resulted in lower treatment-related complication rates.

摘要

目的

比较接受术后放射治疗(RT)的恶性黑色素瘤腋窝淋巴结转移患者,仅对腋窝或腋窝及锁骨上窝(扩大野[EF])进行治疗的相关治疗结局和毒性反应。

方法和材料

回顾性分析200例接受术后RT治疗恶性黑色素瘤腋窝淋巴结转移的连续患者的病历。所有患者因高危特征接受术后大分割RT;95例(48%)患者仅接受腋窝RT,105例(52%)患者接受EF RT。

结果

中位随访59个月时,111例(56%)患者出现持续复发,99例(50%)患者死亡。5年总生存率、无病生存率和无远处转移生存率分别为51%、43%和46%。5年腋窝控制率为88%。根据治疗野不同,腋窝控制率无差异(仅腋窝为89%,EF为86%;p = 0.4)。47例(24%)患者出现治疗相关并发症。单因素和多因素分析均显示,仅EF照射治疗与治疗相关并发症增加显著相关。

结论

对于具有高危特征的转移性恶性黑色素瘤,仅对腋窝进行辅助大分割RT是控制腋窝疾病的有效方法。仅将放射野局限于腋窝可产生与EF相当的腋窝控制率,并导致较低的治疗相关并发症发生率。

相似文献

1
Radiation therapy field extent for adjuvant treatment of axillary metastases from malignant melanoma.用于恶性黑色素瘤腋窝转移辅助治疗的放射治疗野范围
Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1376-82. doi: 10.1016/j.ijrobp.2008.06.1910. Epub 2008 Sep 5.
2
Adjuvant irradiation for axillary metastases from malignant melanoma.恶性黑色素瘤腋窝转移的辅助放疗。
Int J Radiat Oncol Biol Phys. 2002 Mar 15;52(4):964-72. doi: 10.1016/s0360-3016(01)02742-0.
3
Adjuvant radiation therapy after axillary lymphadenectomy for metastatic melanoma: toxicity and local control.转移性黑色素瘤腋窝淋巴结清扫术后的辅助放疗:毒性与局部控制
Ann Surg Oncol. 1995 Sep;2(5):445-9. doi: 10.1007/BF02306379.
4
Feasibility of Postoperative Radiotherapy Using Conventional Fractionation for Lymph Node Metastasis from Cutaneous Melanoma.
Anticancer Res. 2017 Aug;37(8):4239-4246. doi: 10.21873/anticanres.11816.
5
Stage III melanoma in the axilla: patterns of regional recurrence after surgery with and without adjuvant radiation therapy.腋窝 III 期黑色素瘤:辅助放疗与不放疗术后区域复发模式。
Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):702-8. doi: 10.1016/j.ijrobp.2013.03.019.
6
Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.辅助放疗对比单纯观察对于接受过淋巴结清扫术的黑色素瘤患者:一项随机试验。
Lancet Oncol. 2012 Jun;13(6):589-97. doi: 10.1016/S1470-2045(12)70138-9. Epub 2012 May 9.
7
Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.黑色素瘤淋巴结清扫术后的淋巴结区域复发:辅助放疗的意义
Int J Radiat Oncol Biol Phys. 2000 Jan 15;46(2):467-74. doi: 10.1016/s0360-3016(99)00431-9.
8
Locally advanced melanoma: results of postoperative hypofractionated radiation therapy.局部晚期黑色素瘤:术后大分割放疗的结果
Cancer. 2000 Jan 1;88(1):88-94. doi: 10.1002/(sici)1097-0142(20000101)88:1<88::aid-cncr13>3.0.co;2-k.
9
A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma.对黑色素瘤腹股沟淋巴结转移辅助放疗的批判性评估。
Ann Surg Oncol. 2004 Dec;11(12):1079-84. doi: 10.1245/ASO.2004.12.039.
10
Hypofractionated irradiation of infra-supraclavicular lymph nodes after axillary dissection in patients with breast cancer post-conservative surgery: impact on late toxicity.保乳手术后乳腺癌患者腋窝清扫后锁骨上下淋巴结的大分割放疗:对晚期毒性的影响
Radiat Oncol. 2015 Aug 20;10:177. doi: 10.1186/s13014-015-0480-y.

引用本文的文献

1
Adjuvant radiotherapy after salvage surgery for melanoma recurrence in a node field following a previous lymph node dissection.辅助放疗在先前淋巴结清扫后发生淋巴结区域内复发的黑色素瘤患者行挽救性手术后的应用。
J Surg Oncol. 2023 Jul;128(1):97-104. doi: 10.1002/jso.27245. Epub 2023 Mar 27.
2
Factors associated with the use of adjuvant radiation therapy in stage III melanoma.III期黑色素瘤辅助放疗使用的相关因素。
Front Oncol. 2023 Feb 1;13:1005930. doi: 10.3389/fonc.2023.1005930. eCollection 2023.
3
Long noncoding RNA LINC00518 induces radioresistance by regulating glycolysis through an miR-33a-3p/HIF-1α negative feedback loop in melanoma.
长链非编码 RNA LINC00518 通过 miR-33a-3p/HIF-1α 负反馈回路调节糖酵解诱导黑色素瘤放射抵抗。
Cell Death Dis. 2021 Mar 4;12(3):245. doi: 10.1038/s41419-021-03523-z.
4
Clinicopathological Features, Staging, and Current Approaches to Treatment in High-Risk Resectable Melanoma.高危可切除黑色素瘤的临床病理特征、分期和当前治疗方法。
J Natl Cancer Inst. 2020 Sep 1;112(9):875-885. doi: 10.1093/jnci/djaa012.
5
Metastatic Cutaneous Squamous Cell Carcinoma to the Axilla: A Review of Patient Outcomes and Implications for Future Practice.腋窝转移性皮肤鳞状细胞癌:患者预后及对未来实践的启示综述
World J Oncol. 2012 Oct;3(5):217-226. doi: 10.4021/wjon503w. Epub 2012 Oct 28.
6
Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition).《中国黑色素瘤诊疗指南(2015年版)》
Ann Transl Med. 2015 Dec;3(21):322. doi: 10.3978/j.issn.2305-5839.2015.12.23.
7
Role of radiotherapy in melanoma management.放疗在黑色素瘤治疗中的作用。
Radiol Oncol. 2010 Mar;44(1):1-12. doi: 10.2478/v10019-010-0008-x. Epub 2010 Mar 18.
8
Adjuvant Immunotherapy and Radiation in the Management of High-risk Resected Melanoma.高危切除黑色素瘤管理中的辅助免疫治疗与放疗
Ochsner J. 2010 Summer;10(2):108-16.
9
Management of regional lymph node basins in melanoma.黑色素瘤区域淋巴结区域的管理
Ochsner J. 2010 Summer;10(2):99-107.
10
Adjuvant radiation therapy in metastatic lymph nodes from melanoma.辅助放疗在黑色素瘤转移性淋巴结中的应用。
Radiat Oncol. 2011 Feb 6;6:12. doi: 10.1186/1748-717X-6-12.